SureTrader
Interactive Brokers Advertisement
Home > Boards > US OTC > Biotechs >

Oncolix Inc. (ONCX)

ONCX RSS Feed
Add ONCX Price Alert      Hide Sticky   Hide Intro
Moderator: molee, microcaptrdr24, BW, Eltp, Rat Fink, BLight1911
Search This Board: 
Last Post: 12/18/2017 1:48:47 AM - Followers: 162 - Board type: Free - Posts Today: 3



A pharmaceutical company in Harris County, Texas.
OTC: ONCX

14405 Walters Rd, Houston, TX 77014
(281) 402-3168
Contact Us
\

Oncolix, Inc. (Oncolix) is a clinical-stage biotechnology company

We are developing Prolanta™, a targeted therapeutic protein for the treatment of ovarian, breast and other cancers. The Company has a US FDA-cleared IND to commence human testing of Prolanta™ in our first indication, the treatment of ovarian cancer.  This clinical trial began in 2016. Preliminary data from the first dosing group (the low dose) of this trial suggest Prolanta is safe with some evidence of efficacy in a patient population that is difficult to treat. Prolanta™ is a prolactin receptor antagonist that has demonstrated significant efficacy in xenograft models through a unique mechanism of action, autophagy (see Our Science). In addition to ovarian cancer, there is strong preclinical evidence Prolanta™ will be effective in breast, prostate and other cancers.

The FDA has also approved the designation of Prolanta™ as an Orphan Drug for the treatment of ovarian cancer, which may allow reduced filing fees, federal tax credits and marketing exclusivity by the FDA.

Proudly partnered with Greenville Health System

Oncolix, Inc. (Oncolix) is a bio-pharmaceutical company originally established at the Greenville Health System through the innovative efforts of the Oncology Research Institute in conjunction with the GHS Cancer Center drug discovery program. Oncolix, now based in Houston, Texas, is currently focusing on phase one clinical trials of Prolanta™ - a targeted therapeutic protein for the treatment of breast and ovarian cancer. Prolanta™ was pioneered within the Oncology Research Institute (now known as the Clemson Biomedical Institute) at GHS in Greenville, SC.


Proudly partnered with MD Anderson Cancer Treatment Center


MD Anderson has been ranked the No. 1 hospital for cancer care in the nation by U.S. News & World Report’s “Best Hospitals” survey.

 

Oncolix patents

Oncolix has 30 patents in their patent portfolio, including 8 U.S patents.

\

 
AEPP Security Details
Share Structure
  Market Value1 $5,801,028 a/o Dec 01, 2017
Authorized Shares 950,000,000 a/o Dec 01, 2017
Outstanding Shares 103,877,936 a/o Dec 01, 2017
  -Restricted Not Available
  -Unrestricted Not Available
  Held at DTC Not Available
  Float 33,311,633 a/o Apr 06, 2017
  Par Value Not Available
Transfer Agent(s) Verified by Transfer Agent
VStock Transfer LLC
Shareholders
Shareholders of Record 101 a/o Apr 06, 2017

As per OTC markets. Updates are pending


Who is Oncolix, Inc.?

https://oncolixbio.com

April 2017 Company Presentation:
https://nebula.wsimg.com/8b544fcbb6f5bf5fb52c1c7e5a69eb81?AccessKeyId=D34B304F5C474C27E878&disposition=0&alloworigin=1

 

Early funding for Prolactin research was granted from the Susan G. Komen foundation and the U.S government.
More recent funding came from accredited investment including TEXAS TREASURY SAFEKEEPING TRUST CO and the Ernest Mario Family Trust.
Ernest Mario is an American pharmaceutical industry executive and the recipient of the 2007 Remington Honor Medal awarded by the American Pharmacists Association.

 

\

Ernest Mario is the former CEO of GlaxoSmithKilne NYSE: GSK.

He is also Rutgers University alumni who has had the Rutgers School of Pharmacy named after him.


Potential revenue moving forward.

 

 

The Oncolix Team

Management

\

\

Board Members

\

\

\

Company Advisors

\

\

\



 




 


This space reserved for updates.

 



https://www.otcm
arkets.com/edgar/GetFilingHtml?FilingID=12149068

SureTrader
Interactive Brokers Advertisement
ONCX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AEPP News: Current Report Filing (8-k) 12/06/2017 08:47:28 AM
AEPP News: Notice of Effectiveness (effect) 12/01/2017 06:01:32 AM
AEPP News: Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) 11/30/2017 04:29:59 PM
AEPP News: A Personal Letter to the Shareholders from Michael T. Redman, CEO of Oncolix, Inc. 11/29/2017 07:30:00 AM
AEPP News: Securities Registration Statement (s-1/a) 11/29/2017 06:20:36 AM
PostSubject
#14619  Sticky Note 12/6/17 OUTSTANDING CEO INTERVIEW ON PROLANTA_DEVELOPMENT_FOR_WOMEN'S_CANCERS_h Rat Fink 12/09/17 07:21:59 PM
#14089  Sticky Note "ONCX" NEWS JUST OUT!!! "LETTER TO SHAREHOLDERS" FROM_ONCX_CEO!!!_https://financ Rat Fink 11/29/17 09:51:27 AM
#13952  Sticky Note Upcoming milestones after the Ticker Change: rbd317 11/28/17 10:20:22 AM
#13198  Sticky Note Alright, lets review what most people already seem reaper247 11/09/17 12:08:37 AM
#12063  Sticky Note Presentation Recap microcaptrdr24 10/05/17 06:14:18 PM
#14808   Oncolix OTC: ONCX is a pharmaceutical company that reaper247 12/18/17 02:35:35 AM
#14807   Thanks for providing the opportunity to present verifiable reaper247 12/18/17 01:48:47 AM
#14806   LOL, wrong again. reaper247 12/18/17 12:54:58 AM
#14805   Prove that we walked away? Lol. Sungod95 12/17/17 11:19:57 PM
#14804   TREMENDOUS UPSIDE POTENTIAL HERE AS "PROLANTA"_SHOWED,_IN_PRE-CLINICAL_TRIALS,_T Rat Fink 12/17/17 11:18:44 PM
#14803   None of those Patents belong to Oncolix, they laraz5 12/17/17 10:58:21 PM
#14802   BIOPHARMA ONCX/ONCOLIX HAS 8 U.S. PATENTS_AND_MANY_FOREIGN_PATENTS!!! Rat Fink 12/17/17 10:04:59 PM
#14801   Nonsense, the Phase 1 trial has not ended. BLight1911 12/17/17 09:50:44 PM
#14800   LOL Laramshackle5, 1. Study concludes this month and AltJactUp 12/17/17 09:43:05 PM
#14799   LOL! That's just another conspiratorial fairytale about the BODs. zen222 12/17/17 09:34:02 PM
#14798   M.D. ANDERSON'S PRE-CLINCAL TRIAL "ONCOLIX" PROLANTA (G129R) http://nebula.wsim Rat Fink 12/17/17 08:58:30 PM
#14797   That's because the entire BODs are the ones laraz5 12/17/17 08:53:57 PM
#14796   12/12/17 BIOPHARMA ONCOLIX/ONCX OTCQB CERTIFICATION_APPLICATION!!!_https://www.o Rat Fink 12/17/17 08:38:32 PM
#14795   That's completely made up bullshit about the BOD zen222 12/17/17 04:57:12 PM
#14793   Oncolix hasn’t hurt me one bit. Like many BLight1911 12/17/17 02:29:03 PM
#14792   Down yet again this week. So sad the Airstock 12/17/17 01:58:52 PM
#14790   11/29/17 GREAT "LETTER TO SHAREHOLDERS" FROM_"ONCX"_CEO!!!_https://finance.yahoo Rat Fink 12/16/17 08:17:57 PM
#14789   Investors aren’t wanting Oncolix to drop to .01 BLight1911 12/16/17 05:34:15 PM
#14788   12/6/17 OUTSTANDING CEO INTERVIEW ON PROLANTA_DEVELOPMENT_FOR_WOMEN'S_CANCERS_h Rat Fink 12/16/17 04:30:27 PM
#14787   12/12/17 BIOPHARMA ONCOLIX/ONCX OTCQB CERTIFICATION_APPLICATION!!!_https://www.o Rat Fink 12/16/17 03:58:22 PM
#14786   If ONCX goes to .01 Why wouldnt it laraz5 12/16/17 03:40:25 PM
#14783   That's all complete nonsense and baseless bullshit about ONCX. zen222 12/16/17 12:47:29 PM
#14782   What was said this week? BLight1911 12/16/17 11:33:29 AM
#14780   Unfortunately this pyramid scam ONCX is very real laraz5 12/16/17 09:28:30 AM
#14779   Uhhh.... You do ask the tough questions. reaper247 12/16/17 12:44:13 AM
#14778   The cancelled LD Micro conference? The conference that laraz5 12/16/17 12:03:47 AM
#14777   Wait...what? thestreet.com just published this interview with Oncolix CEO reaper247 12/15/17 11:05:02 PM
#14776   Informationists? Bwahahaha... reaper247 12/15/17 10:45:48 PM
#14775   NICE BIOPHARMA "ONCX"/ONCOLIX 13% GAIN TODAY!!! Rat Fink 12/15/17 10:26:02 PM
#14774   More baseless accusations against the CEO of Oncolix. BLight1911 12/15/17 04:01:38 PM
#14773   Green. Sungod95 12/15/17 04:00:59 PM
#14772   And Theres the Paint Michael t Redscam and laraz5 12/15/17 03:56:11 PM
#14771   Sweet. Can't wait to double my shares at .01 pauljon4 12/15/17 03:54:24 PM
#14770   Heh...someone hit the ask for 100 shares. AltJactUp 12/15/17 03:50:39 PM
#14769   LOL! Again, that's just more misinformation and bullshit zen222 12/15/17 03:49:56 PM
#14768   Very little selling in ONCX past few days. namtae 12/15/17 03:39:51 PM
#14767   The lawsuit alleges violations of the Securities Exchange laraz5 12/15/17 03:37:00 PM
#14766   How will ONCX close today? namtae 12/15/17 03:33:57 PM
#14765   At this point, I think I agree with namtae 12/15/17 03:31:35 PM
#14764   There is no evidence that the CEO of BLight1911 12/15/17 03:21:02 PM
#14763   Wonder if Redman paints a positive close with laraz5 12/15/17 03:18:28 PM
#14761   Well for starters, that's all just bullshit misinformation zen222 12/15/17 02:17:26 PM
#14760   I Agree Michael T Redman is avoiding shareholders laraz5 12/15/17 02:04:57 PM
#14759   dance houses and nice cares BLight1911 12/15/17 01:48:43 PM
#14757  Restored 6k volume? Impressive for the next big Airstock 12/15/17 12:46:19 PM
#14755  Restored HAHAHAHAHAHAHAHAHAHAHAHAHAHA! BLight1911 12/15/17 12:25:49 PM
#14753   Bullshit .. molee 12/15/17 12:13:41 PM
#14752   Just sold 6K and will sell in increments BillG2436 12/15/17 12:08:12 PM
#14751   LOL!!! BLight1911 12/15/17 11:01:12 AM
#14750   False on all accounts. Giddyup ONCX!!! CatfishHunter 12/15/17 10:53:32 AM
PostSubject